| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
20 |
| Employees |
1,000 |
| Revenues (TTM) (Millions $) |
179 |
| Net Income (TTM) (Millions $) |
23 |
| Cash Flow (TTM) (Millions $) |
13 |
| Capital Exp. (TTM) (Millions $) |
10 |
Business Description
Bohai Pharmaceuticals Group, Inc.
is a company that specializes in the research, development, production, and distribution of proprietary Chinese medicines in China.
The company was founded in 2006 and is headquartered in Harbin, China.
Bohai Pharmaceuticals focuses on traditional Chinese medicine (TCM) products in four key areas: diabetes, hypertension, rheumatism, and cardio-cerebral vascular diseases.
The company's products are made with natural ingredients, which are sourced from more than 500 herb farms across China, and are manufactured in the company's modern facilities under strict quality control standards.
The company's products are distributed through an extensive network of distributors, wholesalers, and retailers throughout China, including hospitals, pharmacies, and health food stores.
Bohai Pharmaceuticals also exports its TCM products to international markets such as Russia, Kazakhstan, Uzbekistan, and Kyrgyzstan.
In addition to its TCM products, Bohai Pharmaceuticals also provides medical laboratory testing services, including clinical pathology and medical diagnosis services, through its subsidiary, Harbin Tian Di Ren Medical Science and Technology.
The company also operates an online platform, which allows consumers to purchase its TCM products directly.
Bohai Pharmaceuticals is committed to sustainable development, and its facilities are designed with energy-saving and environmental protection in mind.
The company has won several awards for its innovation, social responsibility, and quality control practices.
|
%